Drug Database
Back to search

Poland· PL-100409105

Itulazax

A baumpollen product containing betula verrucosa, registered in Poland by Alk-Abello A/S. The same ATC class is registered in 12 of our 19 countries.

ATC V01AA05

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedItulazaxATCV01AA05REGISTER NO.PL-100409105PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about betula verrucosaAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Baumpollen is registered in 12 of 19 countries.

Countries holding a registration under ATC V01AA05 (baumpollen), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 7 of them publish a price we can compare per daily dose
Search baumpollen products by name

Baumpollen · ATC V01AA05

12 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Betula Verrucosa
Manufacturer
Alk-Abello A/S
Country
Poland (PL)
ATC code
V01AA05
ATC class
Baumpollen
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 2

  • gtin
    05909991420772
  • gtin
    05909991420789

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Baumpollen in 10 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All baumpollen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/43e4ed32-b31d-4717-8dde-813100d39cd5
GET /v1/drugs/43e4ed32-b31d-4717-8dde-813100d39cd5?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Liofilizat podjęzykowy",
  "source": "urpl",
  "strength": "12 SQ-Bet",
  "packaging": "05909991420772 ¦ Rp ¦ 134946\n30 szt.\n05909991420789 ¦ Rp ¦ 134947\n90 szt.",
  "substance": "Betula Verrucosa 12 SQ-Bet",
  "common_name": "Betula Verrucosa",
  "pl_product_id": "100409105",
  "pozwolenie_nr": "25677",
  "auth_procedure": "DCP",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about baumpollen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console